News
Public · Published
Rockwell Medical to Buy Vantive Hemodialysis Business for $125 Million
Rockwell Medical agreed to buy most of the assets and operations of Vantive's hemodialysis business for a base price of $125 million. The deal includes dialysis concentrates, machines, water-treatment systems and a 1-million-square-foot factory in Medolla, Italy, and should close in mid-2027.
Published:
Updated:
What happened
Rockwell Medical agreed to buy most of the assets and operations of Vantive's hemodialysis business for a base price of $125 million. The deal includes dialysis concentrates, machines, water-treatment systems and a 1-million-square-foot factory in Medolla, Italy, and should close in mid-2027.
Confirmed
Global impact / market context
Rockwell is far smaller than the business it is buying. It expects combined annual revenue of $400 million to $450 million versus its own 2026 forecast of $70 million to $75 million, so the purchase would sharply change its size and product range if completed.
Analyst inference
Rockwell plans to pay with two $50 million loans from Vantive plus a $25 million convertible note, which is debt that can later become shares, and up to $45 million more if targets are met. It withdrew 2026 guidance because of deal costs.
Analyst inference
What to watch
- The deal is slated to close in mid-2027, leaving a long wait before the businesses are combined and before investors learn whether the purchase is completed on the agreed terms. Confirmed
- Rockwell plans to fund the purchase with two $50 million term loans and a $25 million convertible note from Vantive, so watch whether those financing arrangements are finalized as described. Proposed
- Vantive may receive up to $45 million more if certain financial milestones are met, so track whether the acquired business hits those targets, since extra payments would raise the final cost. Analyst inference
Evidence
- Original source link unavailable